So many women in this community have described years of bloating, exhaustion, and brain fog that their doctors chalked up entirely to menopause — only to discover later that undiagnosed celiac was layered underneath it all. The cruelest part is that the symptoms overlap so completely that neither condition gets properly treated. If your gut symptoms feel out of proportion to what HRT alone is fixing, this one is worth reading carefully.
Learn more about Rose →Epidemiological studies consistently show a bimodal distribution in celiac disease diagnosis — one peak in early childhood and a second, often underappreciated peak in adults between 40 and 60 years old, with women disproportionately represented in that second wave. This isn't just a detection artifact; emerging evidence suggests hormonal shifts may genuinely lower the threshold at which gluten triggers an autoimmune response in genetically susceptible individuals. Women entering perimenopause who develop new or worsening gastrointestinal symptoms deserve celiac screening, not just a reassurance that 'hormones do this.'
Estrogen receptors are present throughout the gastrointestinal tract, and estrogen actively supports the tight junction proteins that keep the intestinal lining sealed against undigested food particles and pathogens. As estrogen declines during perimenopause, intestinal permeability — sometimes called 'leaky gut' — measurably increases, which may lower the threshold at which gluten peptides trigger an immune cascade in women who carry HLA-DQ2 or HLA-DQ8 gene variants. This is a plausible physiological mechanism for why celiac disease can appear to 'switch on' in midlife, even after decades of apparent gluten tolerance.
Perimenopause does cause genuine gastrointestinal changes — progesterone shifts slow gut motility, and fluctuating estrogen affects serotonin signaling in the gut — so bloating, urgency, and loose stools are legitimately common. The problem is that these symptoms are nearly identical to the 'atypical' presentation of celiac disease that now accounts for the majority of adult diagnoses, meaning celiac gets absorbed into the menopause explanation and never tested for. Women whose gut symptoms don't improve with dietary adjustments or HRT should ask specifically about celiac antibody screening rather than accepting ongoing GI distress as an inevitable menopause side effect.
Estrogen loss after menopause is the most widely known driver of bone density decline, but untreated celiac disease causes its own independent bone loss through calcium and vitamin D malabsorption in the damaged small intestine. When a postmenopausal woman presents with osteoporosis or unexplained low bone density, most clinicians jump straight to hormonal causes and miss the malabsorption component entirely. DEXA scan results that seem worse than expected for a woman's age and hormonal status should prompt a celiac workup, particularly if dietary calcium and vitamin D intake appear adequate.
Iron deficiency after menopause should be less common, not more — once periods stop, the primary source of monthly iron loss disappears. When postmenopausal women present with iron-deficiency anemia, it is a textbook signal that iron absorption is impaired, and celiac disease damaging the duodenum (the primary site of iron absorption) is one of the most important causes to rule out. Gastroenterologists sometimes focus on colonoscopy to rule out bleeding and skip upper endoscopy with duodenal biopsy, which is the only way to confirm or exclude celiac disease with certainty.
Cognitive fog is one of the most distressing and least-explained symptoms of perimenopause, typically attributed to disrupted sleep, fluctuating estrogen, and hypothalamic changes. However, celiac disease is independently associated with neurological symptoms including cognitive dysfunction, and the inflammatory cytokines produced by ongoing gluten exposure cross the blood-brain barrier and impair neurotransmitter function. Women whose brain fog is severe, persistent, or disproportionate to their other menopause symptoms may benefit from exploring whether gluten-related inflammation is amplifying an already challenging hormonal transition.
Autoimmune thyroid disease — including Hashimoto's thyroiditis — clusters with celiac disease, and both conditions share genetic risk factors and autoimmune mechanisms. Hypothyroidism is also more common in perimenopausal women, and its symptoms (fatigue, weight gain, constipation, depression) overlap substantially with both menopause and celiac disease, creating a diagnostic triangle that is notoriously difficult to untangle. Women with known thyroid autoimmunity entering menopause are at meaningfully elevated risk for celiac disease and should discuss proactive screening with their physician rather than waiting for obvious GI symptoms.
The most commonly ordered celiac screening test — anti-tissue transglutaminase IgA (tTG-IgA) — requires normal total IgA levels to be reliable, and IgA deficiency becomes more prevalent with age. Additionally, women who have already reduced their gluten intake informally, often because they noticed feeling better without it, can suppress antibody levels enough to produce a false-negative result even in the presence of ongoing intestinal damage. A thorough workup in a symptomatic midlife woman should include total IgA levels, deamidated gliadin peptide (DGP) antibodies, and ideally HLA genetic typing to properly assess risk before a diagnosis is dismissed.
There is a meaningful difference between celiac disease, non-celiac gluten sensitivity (NCGS), and the wellness-world trend of avoiding gluten without any underlying condition — and conflating them does women a disservice. For women who genuinely have undiagnosed celiac or NCGS, shifting to a strict gluten-free diet can result in dramatic improvements in energy, mood, joint pain, and gastrointestinal comfort that may be mistakenly credited entirely to other menopause interventions happening concurrently. Getting properly tested before going gluten-free — not after — is essential, because it is the only way to know whether the improvement is from treating a real immune condition or simply from a dietary change that happens to reduce ultra-processed food intake.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.